Thomson Reuters Suspends Sale of Healthcare Business

Thomson Reuters (NYSE: TRI), today announced that it has suspended the divestiture process for its Healthcare business. Since announcing the planned divestiture in June, global economic conditions have become more challenging and the company believes they are not conducive to concluding a transaction that reflects the fair value of the Healthcare business at this time. Thomson Reuters is committed to continuing to invest in and grow the Healthcare business until improved market conditions allow the company to complete a divestiture at attractive terms.